The best-defined mechanisms of immune evasion in breast cancer include the production of suppressive immunostimulatory molecules (PD-L1, CTLA4, and LAG-3), abnormal maturation of DCs, and invasion of immunosuppressive cell populations (MDSCs, Tregs, and TAMs). Here, CTLA4 is linked to breast cancer.